Baird Financial Group
IONS icon

Baird Financial Group’s Ionis Pharmaceuticals IONS Stock Holding History

Baird Financial Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,696
Closed -$290K – 1799
2024
Q1 		$290K Buy
6,696
+7
+0.1% +$334 ﹤0.01% 1563
2023
Q4 		$338K Sell
6,689
-85
-1% -$4.07K ﹤0.01% 1476
2023
Q3 		$307K Buy
6,774
+185
+3% +$7.63K ﹤0.01% 1492
2023
Q2 		$270K Sell
6,589
-194
-3% -$7.46K ﹤0.01% 1535
2023
Q1 		$242K Sell
6,783
-110
-2% -$4.13K ﹤0.01% 1563
2022
Q4 		$261K Buy
6,893
+121
+2% +$5.09K ﹤0.01% 1506
2022
Q3 		$300K Sell
6,772
-125
-2% -$5.27K ﹤0.01% 1467
2022
Q2 		$255K Sell
6,897
-3,396
-33% -$128K ﹤0.01% 1610
2022
Q1 		$381K Sell
10,293
-1,063
-9% -$34.8K ﹤0.01% 1527
2021
Q4 		$346K Buy
11,356
+2,407
+27% +$75.8K ﹤0.01% 1608
2021
Q3 		$300K Buy
8,949
+1,553
+21% +$58.5K ﹤0.01% 1666
2021
Q2 		$295K Buy
7,396
+369
+5% +$14.5K ﹤0.01% 1577
2021
Q1 		$316K Buy
+7,027
New +$392K ﹤0.01% 1502
2020
Q3 		– Sell
-4,175
Closed -$246K – 1530
2020
Q2 		$246K Sell
4,175
-1,384
-25% -$77K ﹤0.01% 1366
2020
Q1 		$263K Buy
5,559
+145
+3% +$8.08K ﹤0.01% 1242
2019
Q4 		$327K Sell
5,414
-427
-7% -$25.4K ﹤0.01% 1294
2019
Q3 		$350K Buy
5,841
+17
+0.3% +$1.11K ﹤0.01% 1274
2019
Q2 		$375K Buy
5,824
+2,737
+89% +$193K ﹤0.01% 1274
2019
Q1 		$251K Buy
+3,087
New +$199K ﹤0.01% 1191

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Baird Financial Group's IONS Position: Q2 2024 in Review

Baird Financial Group sold out of Ionis Pharmaceuticals (IONS) in Q2 2024, closing a stake of 6,696 shares — an estimated $290K sold.

Baird Financial Group first reported a position in IONS in Q1 2019 and held it in 19 quarters. The position peaked at $381K in Q1 2022. 356 funds tracked by Wall St. Rank hold IONS as of Q2 2024.

  • Baird Financial Group reported no remaining Ionis Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Baird Financial Group sold 6,696 Ionis Pharmaceuticals shares in Q2 2024, an estimated $290K.
  • Baird Financial Group first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 19 quarters.
  • Baird Financial Group's Ionis Pharmaceuticals position peaked at $381K in Q1 2022.
  • 356 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2024.

Based on Baird Financial Group's 13F filing for Q2 2024, filed 14 Aug 2024.